Las Vegas Sands Corp. (NYSE:LVS): Deutsche Bank believes that there is limited downside in the company’s shares after the recent pullback, and the firm stated that it’s a buyer of the stock at current levels. The firm maintains its Buy rating and a $52 price target on the stock.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): According to Deutsche Bank’s expectations, Congress will increase regulation of compounding pharmacies over time, possibly pressuring demand for Roche’s (RHHBY) Avastin since the drug for wet AMD is made in large quantities at compounding pharmacies. Deutsche believes that branded wet AMD drug sales such as Regeneron’s ylea have the possibility of being a key beneficiary. The firm believes that there is potential upside for Regeneron, and it reiterates its Buy rating and $190 price target on the stock.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Sina Corp. (NASDAQ:SINA) price target has been reduced by Piper Jaffray due to an increasingly difficult environment, but the firm claims that it is encouraged by Weibo’s performance. Piper reiterates its Overweight rating on the stock after the company announced Q3 results.
Dell Inc. (NASDAQ:DELL) continues to hold a Sell rating at Citigroup as a result of the company’s Q3 results. The firm continues to be convinced that consensus earnings estimates are too high and that the Bring Your Own Device, or BOYD, trend is wearing upon Dell’s core strength.
OSI Systems, Inc. (NASDAQ:OSIS): Benchmark Co. predict that allegations of test manipulation will not show much of an impact on OSI Systems, and the firm notes that body scanners themselves are immaterial to the OSI Systems’ revenue during FY12 and FY13. The firm keeps its Buy rating and $90 price target on the stock.
Don’t Miss: Is the New Google Maps for Apple Almost Here?